Ryman Healthcare Limited
Ryman Healthcare Limited
Your view on RYHTY
Overview
What the company does, where it operates, and who runs it.
About Ryman Healthcare Limited
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Naomi James
- Headquarters
- Airport Business Park, Christchurch, NZ
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Naomi James
- Headquarters
- Airport Business Park, Christchurch, NZ
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia.
The company's villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services.
Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hairdressing salons, library, dining room, internet café, bar, lounges, croquet laws, shops, and movie theatre facilities.
As of May 20, 2022, Ryman Healthcare Limited owned and operated 45 retirement villages with approximately 8,538 retirement village units and 4,239 care units. The company was founded in 1984 and is based in Christchurch, New Zealand.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Ryman Healthcare Limited, and the rating behind it. RYHTY last traded at $8.01; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Ryman Healthcare Limited. Starting points for Ryman Healthcare Limited: EPS -$0.84, beta 0.26 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Ryman Healthcare Limited. Ryman Healthcare Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Ryman Healthcare Limited. Trailing twelve-month EPS for Ryman Healthcare Limited stands at -$0.84. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Ryman Healthcare Limited. Ryman Healthcare Limited has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Ryman Healthcare Limited valued side by side against its closest peers. Ryman Healthcare Limited is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Ryman Healthcare Limited, and how their positions are changing. At a $1.40B market value, institutional positions materially move Ryman Healthcare Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Ryman Healthcare Limited executives and directors. Shares of Ryman Healthcare Limited have traded between $6.68 and $10.24 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Ryman Healthcare Limited. Ryman Healthcare Limited is a $1.40B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Ryman Healthcare Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Ryman Healthcare Limited. Coverage tracks Ryman Healthcare Limited within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.